Both in Pharmaceuticals
Organon & vs Parabilis Medicines
Over the past year OGN returned +1.5% and PBLS returned −17.9%; their daily moves had a correlation of 0.00.
OGN +1.5% PBLS −17.9%Growth of $1, one year, split-adjusted
| Metric | OGN | PBLS |
|---|---|---|
| Price | $13.85 | $30.30 |
| Market cap | $3.64B | $3.74B |
| Today | 0.00% | +3.57% |
| 1 month | +0.8% | +5.0% |
| 6 months | +3.3% | — |
| Year to date | +93.2% | — |
| 1 year | +106.4% | — |
| Revenue growth (YoY) | −1.7% | — |
| Gross margin | 55.2% | 100.0% |
| Net margin | 10.4% | −45239.9% |
| P/E (TTM) | 17.1× | — |
| Price / sales | 0.6× | — |
| Net cash | -$7.10B | $1.11B |
| Dividend yield | 0.58% | — |
| Volatility (60d) | 2.9% | — |
| Short % of float | 7.2% | 9.1% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).